Willow Biosciences Inc. (CANSF)

Market Cap	522.60K
Revenue (ttm)	3.24M
Net Income (ttm)	-4.30M
Shares Out	n/a
EPS (ttm)	-0.03
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	23,366
Average Volume	15,253
Open	0.0045
Previous Close	0.0034
Day's Range	0.0045 - 0.0045
52-Week Range	0.0030 - 0.1000
Beta	1.11
RSI	35.89
Earnings Date	May 9, 2025

About Willow Biosciences

Willow Willow Biosciences Inc., a biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical products in the United States. The company has licensing and development partnership with Laurus Labs to develop and commercialize seven API and other ingredients that includes Willow’s BioOxibased processes for production of corticosteroids. Willow Biosciences Inc. was founded in 2019 and is headquartered in Calgary, Canada.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2019
• Employees: 19
• Stock Exchange: OTCMKTS
• Ticker Symbol: CANSF

Financial Performance

In 2024, Willow Biosciences's revenue was 4.66 million, an increase of 297.78% compared to the previous year's 1.17 million. Losses were -6.19 million, -52.50% less than in 2023.

Financial numbers in CAD